{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:23:52Z","timestamp":1793888632043,"version":"4.8.0"},"reference-count":45,"publisher":"American Association for Cancer Research (AACR)","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>This retrospective cohort study of veterans diagnosed with diabetes mellitus evaluated the association between time-varying measures of glycemic control and the time to prostate cancer\u2013specific mortality. Competing risk Cox regression models were developed to estimate the association of glycemic control and prostate cancer mortality for the entire sample and stratified by racial and ethnic groups. A total of 763,424 veterans with type 2 diabetes mellitus (T2DM) were included. In the fully adjusted models, moderate glycemic control [hemoglobin A1c (HbA1c) 7%\u20138%] was associated with a 23% (HR, 0.77; 95% confidence interval, 0.68\u20130.85) lower risk and poor glycemic control (HbA1c &amp;gt;8%) was associated with a 15% (HR, 0.85; 95% confidence interval, 0.71\u20130.99) lower risk of prostate cancer mortality compared with good glycemic control (HbA1c &amp;lt;7%), respectively. In the analyses stratified by race and ethnicity, moderate glycemic control was associated with a lower risk of prostate cancer mortality in non-Hispanic White and non-Hispanic Black veterans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Unlike many other cancers, there is an inverse association between prostate cancer risk and T2DM diagnosis. In this large, retrospective study of male veterans with T2DM, we observed an inverse association between glycemic control and prostate cancer mortality. Further research is required to verify this relationship in prospective studies and identify the potential mechanisms contributing to these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0037","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T11:32:02Z","timestamp":1753183922000},"page":"1256-1265","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Glycemic Control and Prostate Cancer Mortality Risk in Veterans with Type 2 Diabetes Mellitus"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6901-2235","authenticated-orcid":false,"given":"Kinfe G.","family":"Bishu","sequence":"first","affiliation":[{"name":"1Ralph H. Johnson VA Medical Center, Charleston, South Carolina."},{"name":"2Department of Internal Medicine, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0914-3182","authenticated-orcid":false,"given":"Andrew D.","family":"Schreiner","sequence":"additional","affiliation":[{"name":"1Ralph H. Johnson VA Medical Center, Charleston, South Carolina."},{"name":"2Department of Internal Medicine, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8050-8917","authenticated-orcid":false,"given":"Nicholas","family":"Shungu","sequence":"additional","affiliation":[{"name":"3Department of Family Medicine, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7088-859X","authenticated-orcid":false,"given":"Vanessa A.","family":"Diaz","sequence":"additional","affiliation":[{"name":"3Department of Family Medicine, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0706-9040","authenticated-orcid":false,"given":"Macelyn","family":"Batten","sequence":"additional","affiliation":[{"name":"1Ralph H. Johnson VA Medical Center, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4826-481X","authenticated-orcid":false,"given":"Mulugeta","family":"Gebregziabher","sequence":"additional","affiliation":[{"name":"1Ralph H. Johnson VA Medical Center, Charleston, South Carolina."},{"name":"4Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"2025080707265693100_bib1","article-title":"National diabetes statistics report","author":"(CDC) CfDCaP","year":"2024"},{"key":"2025080707265693100_bib2","article-title":"Type 2 diabetes mellitus","author":"(CSPEAR) VCSPEAR","year":"2020"},{"key":"2025080707265693100_bib3","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.2337\/db20-0084","article-title":"Is type 2 diabetes causally associated with cancer risk? Evidence from a two-sample Mendelian randomization study","volume":"69","author":"Yuan","year":"2020","journal-title":"Diabetes"},{"key":"2025080707265693100_bib4","doi-asserted-by":"crossref","first-page":"111665","DOI":"10.1016\/j.diabres.2024.111665","article-title":"Associations between diabetes and cancer: a 10-year national population-based retrospective cohort study","volume":"211","author":"Safadi","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"2025080707265693100_bib5","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/aje\/kwx376","article-title":"Type 2 diabetes and risk of incident cancer in China: a prospective study among 0.5 million Chinese adults","volume":"187","author":"Pan","year":"2018","journal-title":"Am J Epidemiol"},{"key":"2025080707265693100_bib6","doi-asserted-by":"crossref","first-page":"l2368","DOI":"10.1136\/bmj.l2368","article-title":"Role of diet in type 2 diabetes incidence: umbrella review of meta-analyses of prospective observational studies","volume":"366","author":"Neuenschwander","year":"2019","journal-title":"BMJ"},{"key":"2025080707265693100_bib7","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1038\/s41467-021-24861-8","article-title":"An umbrella review of the evidence associating diet and cancer risk at 11 anatomical sites","volume":"12","author":"Papadimitriou","year":"2021","journal-title":"Nat Commun"},{"key":"2025080707265693100_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4093\/dmj.2019.0177","article-title":"Diabetes and cancer: cancer should be screened in routine diabetes assessment","volume":"43","author":"Suh","year":"2019","journal-title":"Diabetes Metab J"},{"issue":"Suppl 1","key":"2025080707265693100_bib9","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.2337\/dc24-S004","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"2025080707265693100_bib10","first-page":"207","article-title":"Diabetes and cancer: a consensus report","volume":"60","author":"Giovannucci","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"2025080707265693100_bib11","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.18632\/aging.205886","article-title":"The association between diabetes mellitus and prostate cancer: a meta-analysis and Mendelian randomization","volume":"16","author":"Ye","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"2025080707265693100_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41416-020-0910-y","article-title":"The association of diabetes with risk of prostate cancer defined by clinical and molecular features","volume":"123","author":"Feng","year":"2020","journal-title":"Br J Cancer"},{"key":"2025080707265693100_bib13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/dmrr.2582","article-title":"Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies","volume":"31","author":"Cai","year":"2015","journal-title":"Diabetes Metab Res Rev"},{"key":"2025080707265693100_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.trsl.2021.07.002","article-title":"Insulin signaling, androgen receptor and PSMA immunohistochemical analysis by semi-automated tissue microarray in prostate cancer with diabetes (DIAMOND study)","volume":"238","author":"Broggi","year":"2021","journal-title":"Transl Res"},{"key":"2025080707265693100_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molmet.2017.11.013","article-title":"Androgen receptor overexpression in prostate cancer in type 2 diabetes","volume":"8","author":"Lutz","year":"2018","journal-title":"Mol Metab"},{"key":"2025080707265693100_bib16","doi-asserted-by":"crossref","first-page":"e6918","DOI":"10.1002\/cam4.6918","article-title":"Interactions of obesity, body shape, diabetes and sex steroids with respect to prostate cancer risk in the UK Biobank cohort","volume":"13","author":"Christakoudi","year":"2024","journal-title":"Cancer Med"},{"key":"2025080707265693100_bib17","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s00125-021-05554-9","article-title":"Racial differences in all-cause mortality and future complications among people with diabetes: a systematic review and meta-analysis of data from more than 2.4 million individuals","volume":"64","author":"Ezzatvar","year":"2021","journal-title":"Diabetologia"},{"key":"2025080707265693100_bib18","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1002\/cncr.34433","article-title":"Racial disparities in Black men with prostate cancer: a literature review","volume":"128","author":"Lillard","year":"2022","journal-title":"Cancer"},{"key":"2025080707265693100_bib19","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/dc10-1504","article-title":"Regional, geographic, and racial\/ethnic variation in glycemic control in a national sample of veterans with diabetes","volume":"34","author":"Egede","year":"2011","journal-title":"Diabetes Care"},{"key":"2025080707265693100_bib20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/1060028014526362","article-title":"Longitudinal effects of medication nonadherence on glycemic control","volume":"48","author":"Egede","year":"2014","journal-title":"Ann Pharmacother"},{"key":"2025080707265693100_bib21","article-title":"VA\/DoD clinical practice guideline for the management of type 2 diabetes mellitus","author":"Department of Veterans Affairs & Department of Defense","year":"2023"},{"key":"2025080707265693100_bib22","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/aje\/kwq070","article-title":"Effect of trajectories of glycemic control on mortality in type 2 diabetes: a semiparametric joint modeling approach","volume":"171","author":"Gebregziabher","year":"2010","journal-title":"Am J Epidemiol"},{"key":"2025080707265693100_bib23","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"2025080707265693100_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1748-0361.2010.00298.x","article-title":"Defining \u201crural\u201d for veterans\u2019 health care planning","volume":"26","author":"West","year":"2010","journal-title":"J Rural Health"},{"key":"2025080707265693100_bib25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/1536867X1301300209","article-title":"Extending the flexible parametric survival model for competing risks","volume":"13","author":"Hinchliffe","year":"2013","journal-title":"Stata J"},{"key":"2025080707265693100_bib26","volume-title":"An introduction to survival analysis using stata","author":"Cleves","year":"2010"},{"key":"2025080707265693100_bib27","volume-title":"Statistical models in epidemiology","author":"Clayton","year":"2013"},{"key":"2025080707265693100_bib28","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00109-021-02096-w","article-title":"High glucose: an emerging association between diabetes mellitus and cancer progression","volume":"99","author":"Supabphol","year":"2021","journal-title":"J Mol Med"},{"key":"2025080707265693100_bib29","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.surg.2019.11.006","article-title":"Postoperative hyperglycemia affects survival after gastrectomy for cancer: a single-center analysis using propensity score matching","volume":"167","author":"Fiorillo","year":"2020","journal-title":"Surgery"},{"key":"2025080707265693100_bib30","first-page":"iv40","article-title":"Obesity and hyperglycemia as a bad prognosis factor for recurrence and survival in colon cancer","volume":"30","author":"Calderillo-Ruiz","year":"2019","journal-title":"Ann Oncol"},{"key":"2025080707265693100_bib31","doi-asserted-by":"crossref","first-page":"732027","DOI":"10.1155\/2012\/732027","article-title":"Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients","volume":"2012","author":"Villarreal-Garza","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"2025080707265693100_bib32","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00125-017-4540-8","article-title":"Hyperglycaemia is associated with cancer-related but not non-cancer-related deaths: evidence from the IPC cohort","volume":"61","author":"Simon","year":"2018","journal-title":"Diabetologia"},{"key":"2025080707265693100_bib33","doi-asserted-by":"crossref","first-page":"e104789","DOI":"10.1371\/journal.pone.0104789","article-title":"Poor glycemic control of diabetes mellitus is associated with higher risk of prostate cancer detection in a biopsy population","volume":"9","author":"Park","year":"2014","journal-title":"PLoS One"},{"key":"2025080707265693100_bib34","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1002\/cncr.32141","article-title":"Poorly controlled diabetes increases the risk of metastases and castration-resistant prostate cancer in men undergoing radical prostatectomy: results from the SEARCH database","volume":"125","author":"Nik-Ahd","year":"2019","journal-title":"Cancer"},{"key":"2025080707265693100_bib35","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ijc.25362","article-title":"Risk of cancer in a large cohort of U.S. veterans with diabetes","volume":"128","author":"Atchison","year":"2011","journal-title":"Int J Cancer"},{"key":"2025080707265693100_bib36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.urolonc.2012.07.008","article-title":"Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence","volume":"30","author":"Pierce","year":"2012","journal-title":"Urol Oncol"},{"key":"2025080707265693100_bib37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.mehy.2009.09.042","article-title":"Why does diabetes offer protective effects against prostate cancer? The possible role of its microvascular complications","volume":"74","author":"Zhang","year":"2010","journal-title":"Med Hypotheses"},{"issue":"Suppl 1","key":"2025080707265693100_bib38","first-page":"S111","article-title":"6. Glycemic goals and hypoglycemia: standards of care in diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2023","journal-title":"Diabetes Care"},{"key":"2025080707265693100_bib39","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.2337\/dc13-2507","article-title":"Severe hypoglycemia identifies vulnerable patients with type 2 diabetes at risk for premature death and all-site cancer: the Hong Kong diabetes registry","volume":"37","author":"Kong","year":"2014","journal-title":"Diabetes Care"},{"key":"2025080707265693100_bib40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/dom.14201","article-title":"Association between visit-to-visit HbA1c variability and the risk of cardiovascular disease in patients with type 2 diabetes","volume":"23","author":"Shen","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"2025080707265693100_bib41","doi-asserted-by":"crossref","first-page":"e2242676","DOI":"10.1001\/jamanetworkopen.2022.42676","article-title":"Statin use and survival among men receiving androgen-ablative therapies for advanced prostate cancer: a systematic review and meta-analysis","volume":"5","author":"Jayalath","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025080707265693100_bib42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/COC.0000000000001012","article-title":"Association between statin exposure and incidence and prognosis of prostate cancer: a meta-analysis based on observational studies","volume":"46","author":"Cao","year":"2023","journal-title":"Am J Clin Oncol"},{"key":"2025080707265693100_bib43","doi-asserted-by":"crossref","first-page":"e81594","DOI":"10.1371\/journal.pone.0081594","article-title":"Insulin therapy and risk of prostate cancer: a systematic review and meta-analysis of observational studies","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"2025080707265693100_bib44","first-page":"259","article-title":"First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH","volume":"30","author":"Griffin","year":"2019","journal-title":"Cancer Causes Control"},{"key":"2025080707265693100_bib45","article-title":"National diabetes statistics report","author":"Control CfD","year":"2024"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0037\/3632496\/crc-25-0037.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/8\/1256\/3637938\/crc-25-0037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/8\/1256\/3637938\/crc-25-0037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T11:27:06Z","timestamp":1754566026000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/8\/1256\/763915\/Glycemic-Control-and-Prostate-Cancer-Mortality"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0037","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.29757260","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29851890","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29757221","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29757242","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29757251","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29757236","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29757224","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29757257","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29757245","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29757266","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29757233","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29757227","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29851905","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29851908","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29851896","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29851899","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29851902","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29851914","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29851911","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7960286","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}